Tortugas takes neuro deep dive with $106M to develop Eisai, Hansoh programs
BioSpace
With programs from Eisai and Hansoh Pharmaceutical in hand, Tortugas Neuroscience has emerged with hopes of delivering daily oral treatments to patients with central nervous system conditions.
pharminent
April 21, 2026 (Last updated: April 21, 2026)
BioSpace
With programs from Eisai and Hansoh Pharmaceutical in hand, Tortugas Neuroscience has emerged with hopes of delivering daily oral treatments to patients with central nervous system conditions.
